AU2003289954A1 - Magnetic resonance imaging which is amplified by a contrast agent with fluid dephasing for representing pathological structures adjacent to blood vessels - Google Patents
Magnetic resonance imaging which is amplified by a contrast agent with fluid dephasing for representing pathological structures adjacent to blood vesselsInfo
- Publication number
- AU2003289954A1 AU2003289954A1 AU2003289954A AU2003289954A AU2003289954A1 AU 2003289954 A1 AU2003289954 A1 AU 2003289954A1 AU 2003289954 A AU2003289954 A AU 2003289954A AU 2003289954 A AU2003289954 A AU 2003289954A AU 2003289954 A1 AU2003289954 A1 AU 2003289954A1
- Authority
- AU
- Australia
- Prior art keywords
- dephasing
- amplified
- fluid
- magnetic resonance
- blood vessels
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Engineering & Computer Science (AREA)
- Signal Processing (AREA)
- High Energy & Nuclear Physics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2002160372 DE10260372B4 (en) | 2002-12-13 | 2002-12-13 | Magnetic resonance imaging apparatus and method for spatially resolved imaging |
DE10260372.3 | 2002-12-13 | ||
PCT/EP2003/013666 WO2004055539A1 (en) | 2002-12-13 | 2003-12-03 | Magnetic resonance imaging which is amplified by a contrast agent with fluid dephasing for representing pathological structures adjacent to blood vessels |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003289954A1 true AU2003289954A1 (en) | 2004-07-09 |
Family
ID=32477899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003289954A Abandoned AU2003289954A1 (en) | 2002-12-13 | 2003-12-03 | Magnetic resonance imaging which is amplified by a contrast agent with fluid dephasing for representing pathological structures adjacent to blood vessels |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1570283A1 (en) |
JP (1) | JP2006509567A (en) |
AU (1) | AU2003289954A1 (en) |
DE (1) | DE10260372B4 (en) |
WO (1) | WO2004055539A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005008753B4 (en) * | 2005-02-25 | 2007-09-27 | Siemens Ag | Method for representing flow in a magnetic resonance image |
DE102005053269B3 (en) * | 2005-11-08 | 2007-04-12 | Siemens Ag | Detection method for determining a diffusion-weighted image of an object under examination in a magnetic resonance facility uses diffusion-weighted and non-diffusion-weighted data records |
US7667460B2 (en) | 2005-11-29 | 2010-02-23 | Koninklijke Philips Electronics N.V. | Distinguishing bound and unbound contrast agents using magnetic resonance |
JP5619339B2 (en) * | 2006-09-13 | 2014-11-05 | 株式会社東芝 | Magnetic resonance imaging system |
US9201129B2 (en) | 2006-09-13 | 2015-12-01 | Kabushiki Kaisha Toshiba | Magnetic-resonance image diagnostic apparatus and method of controlling the same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5922304A (en) | 1989-12-22 | 1999-07-13 | Imarx Pharmaceutical Corp. | Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents |
US6408201B1 (en) * | 2000-06-09 | 2002-06-18 | General Electric Company | Method and apparatus for efficient stenosis identification in peripheral arterial vasculature using MR imaging |
DE10040381C1 (en) | 2000-08-11 | 2002-06-06 | Schering Ag | Perfluoroalkyl-containing complexes with sugar residues, process for their preparation and their use |
-
2002
- 2002-12-13 DE DE2002160372 patent/DE10260372B4/en not_active Expired - Fee Related
-
2003
- 2003-12-03 AU AU2003289954A patent/AU2003289954A1/en not_active Abandoned
- 2003-12-03 EP EP03782298A patent/EP1570283A1/en not_active Withdrawn
- 2003-12-03 WO PCT/EP2003/013666 patent/WO2004055539A1/en active Application Filing
- 2003-12-03 JP JP2004559749A patent/JP2006509567A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2006509567A (en) | 2006-03-23 |
DE10260372B4 (en) | 2007-01-04 |
DE10260372A1 (en) | 2004-07-08 |
WO2004055539A1 (en) | 2004-07-01 |
EP1570283A1 (en) | 2005-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006009751A3 (en) | System and method for monitoring disease progression or response to therapy using multi-modal visualization | |
USD564096S1 (en) | Scanner for a magnetic resonance tomography diagnosis apparatus | |
WO2004052169A3 (en) | Imaging by magnetic resonance adsorption, elastography and tomography | |
AU2003217553A1 (en) | Magnetic resonance imaging capable catheter assembly | |
EP1629773B8 (en) | Magnetic resonance diagnostic apparatus | |
JP2005523065A5 (en) | ||
DE60230842D1 (en) | Magnetic resonance imaging using a preparation run to optimize a pulse sequence | |
AU2003263660A1 (en) | Prenatal diagnosis of down syndrome by detection of fetal rna markers in maternal blood | |
WO2009047966A1 (en) | Blood-vessel ultrasonographing method | |
DE602004009704D1 (en) | CONTROL OF TELEMETRY DURING MAGNETIC RESONANCE IMAGING | |
PT1895902E (en) | Cerebral perfusion monitor | |
WO2007021860A3 (en) | QUANTITATIVE ASSAYS FOR PDGFR-β IN BODY FLUIDS | |
EP1545628A4 (en) | Biochemical methods for measuring metabolic fitness of tissues or whole organisms | |
WO2007003944A3 (en) | Compounds for imaging and therapy | |
AU2003289954A1 (en) | Magnetic resonance imaging which is amplified by a contrast agent with fluid dephasing for representing pathological structures adjacent to blood vessels | |
WO2008015218A3 (en) | Method for diagnosis of a disease involving an anti-at1-receptor antibody | |
AU4855401A (en) | Mr-method for the in vivo measurement of temperature or ph-value by means of a hyperpolarized contrast agent | |
WO2012078752A3 (en) | Serine protease inhibitor kazal antibodies | |
EP1603563A4 (en) | Resonance modulator for diagnosis and therapy | |
WO2006124866A3 (en) | Free human serum ige immunoenzymetric assay and methods of use | |
AU2001231090A1 (en) | Magnetic resonance imaging using contrast agents bioactivated by enzymatic cleavage | |
DE69905238D1 (en) | Device for the complete diagnosis of a driver | |
WO2007031916A3 (en) | Magnetic resonance imaging with several types of contrast | |
AU2003266302A1 (en) | Method for the diagnosis of alzheimer disease | |
AU2003296928A1 (en) | 3d ultrasound-based instrument for non-invasive measurement of amniotic fluid volume |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |